Summary
[Fuxiang Pharmaceutical: The cumulative repurchase of about 6.88 million shares accounted for 1.25%]Fuxiang Pharmaceutical announced on the evening of March 1 that as of February 28, 2022, the company will conduct centralized bidding through a special account for share repurchase securities The transaction method accumulatively repurchased about 6.88 million shares of the company, accounting for 1.25% of the company’s total share capital. The highest transaction price was 17.99 yuan per share, and the lowest transaction price was 12.12 yuan per share. The total amount paid was about 105 million yuan. (Daily Economic News)
Fuxiang PharmaceuticalPosted on the evening of March 1announcementsaid that as of February 28, 2022, the companyreposecuritiesThe special account repurchased about 6.88 million shares of the company in a centralized bidding transaction, accounting for 1.25% of the company’s total share capital. The highest transaction price was 17.99 yuan per share, and the lowest transaction price was 12.12 yuan per share. 105 million yuan.
Fuxiang PharmaceuticalThe chairman of the board is Bao Jianhua, male, 45 years old; the general manager is Qiao Xiaoguang, male, 59 years old, with a master’s degree.
(Article source: Daily Economic News)